Low-Level Laser Therapy and Injectable Platelet-Rich Fibrin for Thin Gingival Phenotype.
NCT ID: NCT06756854
Last Updated: 2025-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
7 participants
INTERVENTIONAL
2023-09-12
2024-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Injectable Platelet Rich Fibrin on Healing and Patient Satisfaction Following Laser Gingival Depigmentation
NCT05283668
Effect of i-PRF and LLLT on Free Gingival Graft Shrinkage
NCT07303192
Er,Cr:YSGG Laser For Recipient Bed Bio-modification And Connective Tissue Harvesting in Treatment of Gingival Recession
NCT03200392
Effect of I-PRF After Gingivectomy
NCT07174934
Laser Biostimulation on Implant Covered With PRF in Controlled Diabetics
NCT06444334
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test group: injectable platelet rich fibrin+ low level laser therapy
patients with thin gingival phenotype (gingival thickness less than 1mm) recieve I-PRF+LLLT radiation just after the injection for 3 sessions with 7 days interval between the sessions.
injecable platelet rich fibrin, and low level laser therapy radiation.
injection of I-PRF+ exposure to LLLT to thin gingival phenotype 3 times with 7 days interval between sessions.
Control group :I-PRF group
patients with thin gingival phenotype received I-PRF alone in 3 sessions, with 7 days interval between the sessions.
Biologic Agent: injectable platelet rich fibrin.
injection of I-PRF to thin gingival phenotype 3 times with 7 days interval between sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biologic Agent: injectable platelet rich fibrin.
injection of I-PRF to thin gingival phenotype 3 times with 7 days interval between sessions.
injecable platelet rich fibrin, and low level laser therapy radiation.
injection of I-PRF+ exposure to LLLT to thin gingival phenotype 3 times with 7 days interval between sessions.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Faculty of Dental Medicine for Girls
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alaa Elsayed
periodontist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed Eldawy, doctor
Role: PRINCIPAL_INVESTIGATOR
MINDRAY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alaa Elsayed
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P-ME-23-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.